Coronavirus (COVID-19)

COVID-19 Vaccines  |   Visitor Policy  |  What to expect when visiting Mercyhealth  |     Mercyhealth FAQ  |  CDC FAQ  |  Antibody Testing Information  |  COVID-19 Lab Testing  |   Virtual Visit... continue reading

Health Library


Return to Index

Uveitis

Uses

  • Acute anterior uveitis
  • Anterior uveitis
  • Irido-cyclitis
  • Iritis
Uveitis is redness and swelling of the middle layer of the eyeball (uvea). There are three types of uveitis based on the part of the eye that is affected. It can cause pain, blurry vision, and sensitivity to light.
It is treated with medicine. Some people turn to natural therapies to further ease symptoms. They must be used with standard treatment.

Natural Therapies

May Be Effective

Not Enough Data to Assess

Editorial process and description of evidence categories can be found at EBSCO NAT Editorial Process.
Editorial process and description of evidence categories can be found at EBSCO NAT Editorial Process.

Herbs and Supplements to Be Used With Caution

Talk to your doctor about any supplements or therapy you would like to use. Some can interfere with treatment or make conditions worse.

References

A
Curcumin
A1
Lal B, Kapoor AK, et al. Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res. 1999;13(4):318-322.
A2
Allegri P, Mastromarino A, et al. Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clin Ophthalmol. 2010;4:1201-1206.
B
Vitamins C, E
B1
van Rooij J, Schwartzenberg SG, et al. Oral vitamins C and E as additional treatment in patients with acute anterior uveitis: a randomised double masked study in 145 patients. Br J Ophthalmol. 1999;83(11):1277-1282.
B2
Nussenblatt RB, Kim J, et al. Vitamin E in the treatment of uveitis-associated macular edema. Am J Ophthalmol. 2006 Jan;141(1):193-194.
C
Echinacea
C1
Neri PG, Stagni E, et al. Oral Echinacea purpurea extract in low-grade, steroid-dependent, autoimmune idiopathic uveitis: a pilot study. J Ocul Pharmacol Ther. 2006 Dec;22(6):431-436.

Revision Information

  • Reviewer: EBSCO NAT Review Board Eric Hurwitz, DC
  • Review Date: 12/2019
  • Update Date: 06/29/2020
Mercyhealth MyChart Sign In